Literature DB >> 34636093

miR-29a-3p promotes migration and invasion in ameloblastoma via Wnt/β-catenin signaling by targeting catenin beta interacting protein 1.

Sai Liu1, Dongjuan Liu1, Jinwen Liu1, Jiayi Liu1, Ming Zhong1,2.   

Abstract

BACKGROUND: Ameloblastoma (AB) is a common epithelial odontogenic tumor. The Wnt/β-catenin pathway has been found to be related to AB invasion.
METHODS: The alteration expression of microRNAs (miRNAs) and messenger RNAs (mRNAs) was performed by miRNA and mRNA microarray analysis and validated by quantitative real-time polymerase chain reaction (RT-PCR). The effects of miR-29a-3p on migration and invasion in AB cells were evaluated by a transwell assay. Bioinformatic prediction was conducted using the miRSystem and validated by quantitative RT-PCR, western blot, and a luciferase reporter assay.
RESULTS: miR-29a-3p was overexpressed in AB tissues, which promoted the migration and invasion of AB cells in vitro. Catenin beta interacting protein 1 (CTNNBIP1), a negative regulator of the Wnt/β-catenin pathway, was predicted to be a target of miR-29a-3p. miR-29a-3p inhibited the expression of CTNNBIP1 and promoted the expression of the downstream molecules of the Wnt/β-catenin pathway.
CONCLUSIONS: miR-29a-3p promoted migration and invasion in AB via Wnt/β-catenin signaling by targeting CTNNBIP1.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  Wnt/β-catenin signaling; ameloblastoma; catenin beta interacting protein 1; invasion; miR-29a-3p

Mesh:

Substances:

Year:  2021        PMID: 34636093     DOI: 10.1002/hed.26888

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  miR-29a-3p inhibits the malignant characteristics of non-small cell lung cancer cells by reducing the activity of the Wnt/β-catenin signaling pathway.

Authors:  Kang Zhang; Xiaoliang Han; Wenbin Hu; Chao Su; Binjun He
Journal:  Oncol Lett       Date:  2022-09-12       Impact factor: 3.111

Review 2.  Ameloblastoma: An Updated Narrative Review of an Enigmatic Tumor.

Authors:  Suhani Ghai
Journal:  Cureus       Date:  2022-08-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.